ETF Holdings Breakdown of SVRA

SVRA institutional holdings

The following institutional investment holdings of SVRA have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	110,531	USD 478,599 7.6%	4.33
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	110,531	USD 478,599 7.6%	4.33
Total =		221,062	USD 957,198

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with SVRA

Savara (NASDAQ:SVRA) Price Target Raised to $11.00 at Guggenheim

Savara (NASDAQ:SVRA – Get Free Report) had its price objective hoisted by stock analysts at Guggenheim from $8.00 to $11.00 in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective would indicate a potential upside of 187.21% from the […] - 2025-09-11 03:04:49

Savara (NASDAQ:SVRA) Given New $8.00 Price Target at Oppenheimer

Savara (NASDAQ:SVRA – Get Free Report) had its price objective boosted by Oppenheimer from $6.00 to $8.00 in a research report issued on Monday, MarketBeat.com reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 109.42% from the company’s current price. Several other research firms […] - 2025-09-10 03:00:54

HC Wainwright Increases Savara (NASDAQ:SVRA) Price Target to $8.00

Savara (NASDAQ:SVRA – Get Free Report) had its price objective lifted by HC Wainwright from $5.00 to $8.00 in a report released on Wednesday, MarketBeat Ratings reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would indicate a potential upside of 123.46% from the stock’s current price. Several other […] - 2025-09-05 05:03:17

Savara (NASDAQ:SVRA) Stock Price Up 4.8% After Analyst Upgrade

Savara Inc. (NASDAQ:SVRA – Get Free Report) shares shot up 4.8% on Wednesday after HC Wainwright raised their price target on the stock from $5.00 to $8.00. HC Wainwright currently has a buy rating on the stock. Savara traded as high as $3.48 and last traded at $3.47. 203,938 shares traded hands during trading, a […] - 2025-09-05 02:15:53

Oppenheimer Increases Savara (NASDAQ:SVRA) Price Target to $6.00

Savara (NASDAQ:SVRA – Free Report) had its target price raised by Oppenheimer from $5.00 to $6.00 in a report released on Friday,Benzinga reports. They currently have an outperform rating on the stock. Other equities analysts also recently issued research reports about the company. Evercore ISI dropped their price target on Savara from $3.00 to $2.00 […] - 2025-08-18 04:49:02

Savara (NASDAQ:SVRA) Stock Rating Upgraded by HC Wainwright

HC Wainwright upgraded shares of Savara (NASDAQ:SVRA – Free Report) from a neutral rating to a buy rating in a report published on Friday, Marketbeat Ratings reports. HC Wainwright currently has $5.00 price objective on the stock, up from their prior price objective of $2.00. Several other brokerages also recently commented on SVRA. Evercore ISI […] - 2025-08-18 03:05:06

Savara Inc. (NASDAQ:SVRA) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Savara Inc. (NASDAQ:SVRA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five ratings firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average […] - 2025-07-25 05:14:50

Alps Advisors Inc. Lowers Holdings in Savara Inc. (NASDAQ:SVRA)

Alps Advisors Inc. lessened its position in shares of Savara Inc. (NASDAQ:SVRA – Free Report) by 16.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 115,752 shares of the company’s stock after selling 23,019 shares during the quarter. Alps Advisors Inc.’s holdings […] - 2025-07-18 04:48:57

Nuveen Asset Management LLC Cuts Position in Savara Inc (NASDAQ:SVRA)

Nuveen Asset Management LLC lessened its position in shares of Savara Inc (NASDAQ:SVRA – Free Report) by 7.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 384,779 shares of the company’s stock after selling 30,766 shares during the quarter. Nuveen Asset […] - 2025-06-05 04:55:08

ProShare Advisors LLC Grows Stock Position in Savara Inc (NASDAQ:SVRA)

ProShare Advisors LLC grew its position in shares of Savara Inc (NASDAQ:SVRA – Free Report) by 28.8% during the fourth quarter, HoldingsChannel reports. The firm owned 40,627 shares of the company’s stock after buying an additional 9,096 shares during the period. ProShare Advisors LLC’s holdings in Savara were worth $125,000 as of its most recent […] - 2025-06-03 04:48:47

Brokerages Set Savara Inc (NASDAQ:SVRA) Target Price at $7.17

Shares of Savara Inc (NASDAQ:SVRA – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The […] - 2025-06-03 03:07:08

Two Sigma Investments LP Buys 127,628 Shares of Savara Inc (NASDAQ:SVRA)

Two Sigma Investments LP grew its stake in shares of Savara Inc (NASDAQ:SVRA – Free Report) by 19.4% during the fourth quarter, HoldingsChannel reports. The firm owned 785,477 shares of the company’s stock after purchasing an additional 127,628 shares during the quarter. Two Sigma Investments LP’s holdings in Savara were worth $2,411,000 at the end […] - 2025-06-01 06:04:54

Wells Fargo & Company Has Lowered Expectations for Savara (NASDAQ:SVRA) Stock Price

Savara (NASDAQ:SVRA – Free Report) had its target price trimmed by Wells Fargo & Company from $8.00 to $7.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price on shares […] - 2025-05-29 03:14:54

Deutsche Bank AG Has $2.85 Million Position in Savara Inc (NASDAQ:SVRA)

Deutsche Bank AG boosted its holdings in Savara Inc (NASDAQ:SVRA – Free Report) by 6.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 927,595 shares of the company’s stock after buying an additional 53,054 shares during the quarter. Deutsche […] - 2025-05-22 05:06:48

Hsbc Holdings PLC Invests $48,000 in Savara Inc (NASDAQ:SVRA)

Hsbc Holdings PLC purchased a new position in shares of Savara Inc (NASDAQ:SVRA – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 15,627 shares of the company’s stock, valued at approximately $48,000. A number of other hedge funds and other institutional investors have also modified their holdings of SVRA. Dimensional Fund Advisors […] - 2025-05-13 04:26:47

Geode Capital Management LLC Raises Stake in Savara Inc (NASDAQ:SVRA)

Geode Capital Management LLC increased its stake in Savara Inc (NASDAQ:SVRA – Free Report) by 2.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,784,037 shares of the company’s stock after purchasing an additional 57,187 shares during the quarter. Geode Capital Management […] - 2025-04-24 04:30:49

Analysts Set Savara Inc (NASDAQ:SVRA) Price Target at $8.83

Shares of Savara Inc (NASDAQ:SVRA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average […] - 2025-04-14 02:59:04

Savara Launches New Dried Blood Spot Test For APAP Diagnosis

(RTTNews) - Savara Inc. (SVRA), a biopharmaceutical company, Thursday announced that it has introduced the aPAP ClearPath Dried Blood Spot Test in the U.S. - 2025-03-06 12:34:33

Brokerages Set Savara Inc (NASDAQ:SVRA) Price Target at $9.86

Shares of Savara Inc (NASDAQ:SVRA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average […] - 2025-02-25 06:54:58

China Universal Asset Management Co. Ltd. Acquires 4,732 Shares of Savara Inc (NASDAQ:SVRA)

China Universal Asset Management Co. Ltd. boosted its position in Savara Inc (NASDAQ:SVRA – Free Report) by 14.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 36,390 shares of the company’s stock after buying an additional 4,732 shares during the quarter. China Universal […] - 2025-02-04 07:15:10

Brokerages Set Savara Inc (NASDAQ:SVRA) PT at $9.86

Shares of Savara Inc (NASDAQ:SVRA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average […] - 2025-01-31 06:59:13

Back to Listing

Disclaimer